Peter Altman Bio Cardia, Inc. (BCDA) insider trading activity

Peter Altman is President and CEO of BioCardia, Inc.. Currently has a direct ownership of 168,062 shares of BCDA, which is worth approximately $292,427. The most recent transaction as insider was on Aug 13, 2025, when has been sold 100 shares (Common Stock) at a price of $1.83 per share, resulting in proceeds of $183. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K

18.63% 3M change

322.85% 12M change

Total Value Held $292,427

Peter Altman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 13 2025	BUY Open market or private purchase	$183 $1.83 p/Share	100 Added 0.06%	168,062 Common Stock
Aug 12 2025	BUY Open market or private purchase	$700 $1.75 p/Share	400 Added 0.24%	167,962 Common Stock
Aug 11 2025	BUY Open market or private purchase	$2,992 $1.76 p/Share	1,700 Added 1.0%	167,562 Common Stock
Jun 30 2025	BUY Open market or private purchase	$50,119 $2.08 p/Share	24,096 Added 12.68%	165,862 Common Stock
May 30 2025	BUY Open market or private purchase	$221 $2.21 p/Share	100 Added 0.07%	141,766 Common Stock
May 22 2025	BUY Open market or private purchase	$1,323 $1.89 p/Share	700 Added 0.49%	141,666 Common Stock
May 20 2025	BUY Open market or private purchase	$3,328 $2.08 p/Share	1,600 Added 1.12%	140,966 Common Stock
May 16 2025	BUY Open market or private purchase	$729 $2.43 p/Share	300 Added 0.21%	139,366 Common Stock
May 14 2025	BUY Open market or private purchase	$299 $2.99 p/Share	100 Added 0.07%	139,066 Common Stock
Apr 23 2025	BUY Open market or private purchase	$49,867 $1.9 p/Share	26,246 Added 15.89%	138,966 Common Stock
Apr 15 2025	BUY Open market or private purchase	$214 $2.14 p/Share	100 Added 0.09%	112,720 Common Stock
Apr 11 2025	BUY Open market or private purchase	$608 $2.03 p/Share	300 Added 0.27%	112,620 Common Stock
Apr 10 2025	BUY Open market or private purchase	$597 $1.99 p/Share	300 Added 0.27%	112,320 Common Stock
Apr 07 2025	BUY Open market or private purchase	$980 $1.96 p/Share	500 Added 0.44%	112,020 Common Stock
Apr 04 2025	BUY Open market or private purchase	$1,632 $2.04 p/Share	800 Added 0.71%	111,520 Common Stock
Apr 03 2025	BUY Open market or private purchase	$1,320 $2.2 p/Share	600 Added 0.54%	110,720 Common Stock
Apr 03 2025	BUY Open market or private purchase	$2,688 $2.24 p/Share	1,200 Added 1.08%	109,620 Common Stock
Apr 02 2025	BUY Open market or private purchase	$1,115 $2.23 p/Share	500 Added 0.45%	110,120 Common Stock
Mar 03 2025	BUY Open market or private purchase	$1,055 $2.11 p/Share	500 Added 0.46%	108,420 Common Stock
Feb 07 2025	BUY Open market or private purchase	$1,488 $2.48 p/Share	600 Added 0.55%	107,920 Common Stock
Jan 30 2025	BUY Open market or private purchase	$568 $2.38 p/Share	239 Added 0.22%	107,320 Common Stock
Jan 29 2025	BUY Open market or private purchase	$1,200 $2.4 p/Share	500 Added 0.46%	107,081 Common Stock
Dec 23 2024	BUY Open market or private purchase	$2,060 $2.06 p/Share	1,000 Added 0.93%	106,581 Common Stock
Dec 05 2024	BUY Open market or private purchase	$555 $2.22 p/Share	250 Added 0.24%	105,581 Common Stock
Nov 15 2024	BUY Open market or private purchase	$2,524 $1.87 p/Share	1,350 Added 1.27%	105,331 Common Stock

Peter Altman

President and CEO

Sunnyvale, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCardia, Inc.

Track Activities on BCDA

Account